This Week in Cardiology: Lupus Risk and Heart Failure Interventions

From the New England Journal of Medicine, a meta-analysis examined data from over 2.5 million individuals to find that systemic lupus erythematosus is associated with a higher risk of coronary artery disease ^[1].

The authors note that while the elevated risk is clear, there is currently a lack of genetic evidence supporting a direct causal link between the two conditions.

Meanwhile, research published in the Journal of the American Heart Association highlighted persistent symptoms despite aggressive treatment. In a randomized controlled trial involving patients with chronic coronary disease, findings suggest that residual angina occurs in 42.2% of participants even after anatomic complete revascularization ^[3].

The study indicates that this residual pain does not appear to increase mortality rates, yet it remains a significant consideration for symptomatic management.

Elsewhere this week, the focus shifted to procedural interventions for heart failure and stroke prevention. In a randomized trial involving 2118 patients undergoing valve repair or replacement, surgical left atrial appendage occlusion failed to lower stroke or cardiovascular death rates compared to standard care ^[2].

Conversely, a separate study in the European heart journal. Cardiovascular Imaging reported that mitral transcatheter edge-to-edge repair (M-TEER) reduced the risk of cardiovascular death or heart failure hospitalization across all baseline health status levels in patients with mitral regurgitation ^[5].

Finally, a multicenter randomized clinical trial enrolled 982 patients with acute heart failure to evaluate a simplified transitional care intervention ^[4].

The results described in the Journal of the American Heart Association indicate that this approach did not improve guideline adherence over a 6-month follow-up period. These varied findings underscore the complexity of managing comorbidities and optimizing outcomes in diverse patient populations.